Background {#Sec1}
==========

Acute coronary syndromes (ACS) represent a common cause for hospital admissions and mortality in patients with cardiovascular disease. In patients with non-ST elevation myocardial infarction (NSTEMI), an early invasive strategy, in patients without contraindications or prohibitive comorbidities, is superior to a selective invasive strategy in reducing rehospitalization and myocardial infarction (MI) \[[@CR1],[@CR2]\]. Indeed, guidelines endorse an early invasive strategy defined as cardiac catheterization and revascularization within 48--72 hours of presentation for high-risk patients \[[@CR3]--[@CR6]\]. However, patients with ACS usually present to the nearest acute care facilities for evaluation and management. These are often community hospitals that lack cardiac catheterization and revascularization (percutaneous coronary intervention \[PCI\] and coronary artery bypass grafting \[CABG\]) abilities. Efficient inter-hospital transfer between community and tertiary centers is therefore necessary to provide access to these procedures. Previous studies have demonstrated that a significant number of ACS patients in the community do not get transferred to interventional capable centers for invasive management \[[@CR7]--[@CR9]\].

We have developed a large, population-based clinical registry that captures all patients undergoing cardiac catheterization and revascularization in Alberta, Canada since 1995. The subsequent expansion of this registry to include all cardiac admissions in Southern Alberta provides a unique opportunity to examine practice patterns (such as transfer for cardiac catheterization) and outcomes in unselected ACS patients. The purpose of this study was to evaluate process of care within a regional care model by comparing cardiac catheterization and revascularization rates and outcomes in ACS patients presenting to community and interventional hospitals.

Methods {#Sec2}
=======

All data were derived from the Alberta Provincial Program for Outcome Assessment in Coronary Heart disease (APPROACH). APPROACH is an ongoing prospective cohort study of all Alberta residents undergoing cardiac catheterization for coronary artery disease since 1995, which expanded in 2004 to include cardiac admissions in Southern Alberta. The initiative has been previously described \[[@CR10]\]. In brief, this population-based, multiple-year inception cohort database contains detailed information on socio-demographic characteristics, presence of risk factors and comorbidities, disease-specific variables, coronary catheterization results, post-catheterization referral decisions, records of actual revascularization and long-term outcomes including survival and quality of life. Data from APPROACH are routinely enhanced by merging the clinical registry data to administrative records to supplement clinical information available on all patients. This data enhancement methodology has been validated and previously reported \[[@CR11]\]. Patient survival from catheterization and/or revascularization until death is ascertained through semi-annual linkage to Alberta Vital Statistics records. The APPROACH registry has an approved privacy impact assessment. The University of Calgary and University of Alberta Research Ethics Boards have approved APPROACH registry data collection and linkages with secondary sources.

For the present study we identified all patients over the age of 18 with ACS (NSTEMI and unstable angina (UA)) admitted to hospitals in Southern Alberta. This region is a large geographic area of over 1.6 million people served by one interventional center in the city of Calgary with a constellation of smaller community hospitals in surrounding areas. This Calgary Health Region is one of the largest, fully integrated health care systems in Canada.

Patients were categorized according to location and facilities available in the hospital of initial admission: 1) community hospitals: comprised of secondary referral centers staffed by specialists and/or general practitioners and smaller primary centers without on-site specialty physicians. All community centers lack on-site cardiac catheterization facilities and are located a minimum of 49 kilometers (km) and a maximum of 291 km (average 220 km) from the interventional center, 2) interventional hospital: the only tertiary care center with on-site cardiac catheterization and revascularization abilities and cardiology specialists. Each rural region has independent ACS management protocols, however, when a patient requiring cardiac catheterization is identified, referring physicians complete a standard referral form that is sent to the catheterization center by fax, along with relevant history, GRACE score, laboratory data, and other tests if applicable. When the referral is complete, it is reviewed by a member of the interventional cardiology group for approval and triage for urgency and arrangements for transport to the interventional center are made.

Statistical analysis {#Sec3}
--------------------

The primary outcomes of interest were cardiac catheterization and revascularization rates during index admission among patients admitted to community versus interventional hospitals. Baseline comparisons of clinical characteristics between patient groups were made by the Chi Square Test for categorical variables and by ANOVA for continuous variables. Kaplan-Meier analysis was used to present the unadjusted thirty-day and one-year survival rates from the index hospitalization for each patient group. Cox proportional hazard models were then used to calculate survival following risk adjustment for the clinical characteristics and comorbidities presented in Table [1](#Tab1){ref-type="table"}. All analyses were conducted using SAS 9.2, (Cary, North Carolina).Table 1**Baseline characteristicsCharacteristicInterventional N =3562Community N =2592p value**Age (years)66.4 ± 12.666.3 ± 13.00.84Male2474 (69.5%)1768 (68.2%)0.31Diabetes872 (24.5%)678 (26.2%)0.14Hypertension2357 (66.2%)1732 (66.8%)0.59Dyslipidemia2636 (74.0%)1999 (77.1%)0.005Smoker675 (19.0%)660 (25.5%)\<0.0001Previous MI959 (26.9%)677 (26.2%)0.50Previous PCI880 (24.7%)484 (18.7%)\<0.0001Previous CABG413 (11.6%)227 (8.8%)0.0003Previous heart failure252 (7.1%)238 (9.2%)0.003Chronic renal failure115 (3.2%)74 (2.9%)0.40Acute renal failure10 (0.3%)10 (0.4%)0.48Dialysis76 (2.1%)29 (1.1%)0.002Cerebrovascular disease292 (8.2%)196 (7.6%)0.36Peripheral vascular disease172 (4.8%)137 (5.2%)0.46Mean heart rate (beats/min)75.5 (19.3)76.5 (20.2)0.05Mean systolic BP (mmHg)138.8 (25.7)142.1 (27.4)\<0.0001Mean diastolic BP (mmHg)77.8 (16.2)80.2 (17.4)\<0.0001Systolic BP \< 100136 (3.9%)106 (4.2%)0.63Presence of shock32 (0.9%)18 (0.7%)0.38ECG dynamic changes419 (11.8%)437 (16.9%)\<0.0001Presentation diagnosis\<0.0001Unstable angina2286 (42.5)1334 (33.7)NSTEMI1276 (23.7)1259 (31.7)Non-invasive tests^†^ performed within 3 months prior to admission471 (13.2%)288 (11.1%)0.013Catheterization not received1730 (48.6%)1834 (32.2%)\<0.0001Catheterization received11832 (51.4%)1759 (67.8%)Within 24 hours of admission594 (16.7%)255 (9.8%)\<0.0001Within 48 hours of admission995 (54.3%)571 (32.5%)\<0.0001Within 72 hours of admission1260 (68.8%)844 (48%)\<0.0001Values are expressed as mean ± SD and number (%).*MI* = Myocardial infarction, *PCI* = Percutaneous coronary intervention, *CABG* = Coronary artery bypass grafting, *BP* = Blood pressure, *ECG* = Electrocardiogram, *mmHg* = Millimeters of mercury, *NSTEMI* = Non-ST elevation myocardial infarction.^†^Non-invasive tests includes nuclear thallium, stress ECHO, treadmill, CT, MRI and peripheral angiography.

Results {#Sec4}
=======

Our cohort consisted of 6154 ACS patients admitted to hospitals in Southern Alberta between January 1, 2005 and December 31, 2009. Of these patients, 2592 (42.1%) were admitted initially to community hospitals and 3562 (57.9%) to the interventional center. Baseline patient characteristics were analyzed according to type of admitting hospital (Table [1](#Tab1){ref-type="table"}) and cardiac catheterization status (Table [2](#Tab2){ref-type="table"}). Smoking, dyslipidemia, previous heart failure, initial diagnosis of NSTEMI and the presence of dynamic electrocardiogram changes were all more prevalent in patients admitted to community hospitals. Patients admitted to the interventional hospital more commonly had a history of previous revascularization (PCI /CABG) and were more likely to be on dialysis than those admitted to community hospitals.Table 2**Baseline characteristics and cardiac catheterization statusInterventionalCommunityCharacteristicNo cath N = 1,730Cath N = 1,832P-valueNo cath N = 791Cath N = 1,801P-valueOverall P-value**Age (years)68.1 (13.2)64.8 (11.9)\<0.000169.6 (14.6)64.9 (12.0)\<0.0001\<0.0001Male1,147 (66.3%)1,327 (72.4%)\<0.0001472 (59.7%)1,296 (72.0%)\<0.0001\<0.0001Diabetes441 (25.5%)431 (23.5%)0.173216 (27.3%)462 (25.7%)0.3770.18Hypertension1,157 (66.9%)1,200 (65.5%)0.386511 (64.6%)1,221 (67.8%)0.1120.32Dyslipidemia1,227 (70.9%)1,409 (76.9%)\<0.0001513 (64.9%)1,486 (82.5%)\<0.0001\<0.0001Smoker310 (17.9%)365 (19.9%)0.127157 (19.9%)503 (27.9%)\<0.0001\<0.0001Previous MI496 (28.7%)463 (25.3%)0.022246 (31.1%)431 (23.9%)0.00010.0002Previous PCI449 (26.0%)431 (25.3%)0.093140 (17.7%)344 (19.1%)0.399\<0.0001Previous CABG235 (13.6%)178 (9.7%)0.000391 (11.5%)136 (7.6%)0.001\<0.0001Previous heart failure162 (9.4%)90 (4.9%)\<0.0001123 (15.6%)115 (6.4%)\<0.0001\<0.0001Chronic renal failure66 (3.8%)49 (2.7%)0.05427 (3.4%)47 (2.6%)0.2580.12Acute renal failure7 (0.4%)3 (0.2%)0.1758 (1.0%)2 (0.1%)0.00070.001Dialysis43 (2.5%)33 (1.8%)0.15810 (1.3%)19 (1.1%)0.6410.008Cerebrovascular disease149 (8.6%)143 (7.8%)0.38079 (10.0%)117 (6.5%)0.0020.013Peripheral vascular disease89 (5.1%)83 (4.5%)0.39353 (6.7%)83 (4.6%)0.0280.097Mean heart rate (beats/min)74.6 (19.8)76.3 (18.9)0.01279.2 (20.6)75.4 (20.0)\<0.0001\<0.0001Mean systolic BP (mmHg)136.8 (25.7)140.7 (25.6)\<0.0001140.7 (27.8)142.7 (27.2)0.092\<0.0001Mean diastolic BP (mmHg)75.7 (15.9)79.8 (16.2)\<0.000178.0 (17.0)81.2 (17.5)\<0.0001\<0.0001Systolic BP \< 10078 (4.7)58 (3.2)0.02939 (5.1)67 (3.8)0.1420.068Presence of shock13 (0.8%)19 (1.0%)0.3679 (1.1%)9 (0.5%)0.0720.22ECG dynamic changes189 (10.9%)230 (12.6%)0.131138 (17.5%)299 (16.6%)0.597\<0.0001Presentation diagnosis\<0.0001\<0.0001\<0.0001Unstable angina523 (30.2%)753 (41.1%)306 (38.7%)953 (52.9%)NSTEMI1,207 (69.8%)1,079 (58.9%)485 (61.3%)848 (47.1%)Non-invasive tests^†^ performed within 3 month prior to admission360 (20.8%)256 (14.0%)\<0.0001100 (12.6%)248 (13.8%)0.438\<0.0001Values are expressed as mean ± SD and number (%).*MI* = Myocardial infarction, *PCI* = Percutaneous coronary intervention, *CABG* = Coronary artery bypass grafting, *BP* = Blood pressure, *ECG* = Electrocardiogram, *mmHg* = Millimeters of mercury, *NSTEMI* = Non-ST elevation myocardial infarction.^†^Non-invasive tests includes nuclear thallium, stress ECHO, treadmill, CT, MRI and peripheral angiography.

Figure [1](#Fig1){ref-type="fig"} depicts cardiac catheterization and revascularization rates according to type of admitting hospital. Catheterization was performed more frequently in patients initially admitted to community hospitals than those admitted initially to the interventional facility (respectively 69.5% and 51.4%, p \< 0.0001). In patients undergoing catheterization, revascularization (PCI and/or CABG) was also performed more frequently in the community group compared to the interventional group (respectively, 74.5% and 56.1%, P \< 0.0001). The overall mean time to cardiac catheterization was 3.2 days. Patients admitted to the interventional center underwent catheterization sooner than those admitted to community centers (2.6 vs. 4 days, p \< 0.001). In the interventional group, 9.8% underwent catheterization within 24 hours of admission compared to 16.7% in the community group. Within 48 hours from admission, 32.5% and 54.3% of the interventional and community patients underwent catheterization and within 72 hours, 48% and 68.3% had undergone the procedure (p \< 0.0001).Figure 1**Cardiac catheterization and revascularization rates by presenting hospital (Revascularization defined as percutaneous coronary intervention or coronary artery bypass grafting).** Catheterization: Int 1,832 (51.4%) vs. comm 1,801 (69.5%), P\<0.0001.Revascularization: Int 1,027 (56.1%) vs. comm 1,342 (74.5%), P\<0.0.

Figure [2](#Fig2){ref-type="fig"} demonstrates Kaplan Meier survival curves extending to one year of follow up. There was an early separation of the curves that persisted with longer follow-up, with crude mortality rates significantly lower in patients undergoing cardiac catheterization in both community (12.7% vs. 3.5%) and interventional (9.1% vs. 4.2%) centers p \< 0.0001. Survival was lower for patients not referred for catheterization from an admitting community hospital compared to patients first admitted to the interventional center but not referred for catheterization (87.3% vs. 90.9%, p = 0.003).Figure 2**Kaplan Meier plot demonstrating survival from admission with acute coronary syndrome stratified by cardiac catheterization status (C = community hospitals, M = metropolitan hospitals, I = interventional hospital, cath = cardiac catheterization).**

Table [3](#Tab3){ref-type="table"} demonstrates crude and adjusted hazard ratios for our cohort. After adjusting for baseline risk factor characteristics seen in Table [1](#Tab1){ref-type="table"}, no difference in outcome at 30 days or 1 year was noted between those admitted to the interventional center and those initially admitted to community centers.Table 3**Hazard ratios for 30-day and 1-year mortalityCardiac cath statusPresenting hospital30-day crude HR (95% CI)30-day adjusted HR (95% CI)1-year crude HR (95% CI)1-year adjusted HR (95% CI)**CathInterventional**ReferenceReferenceReferenceReference**CathCommunity1.16 (0.65, 2.05)1.04 (0.58, 1.85)0.84 (0.60, 1.18)0.79 (0.56, 1.11)No CathInterventional2.58 (1.57, 4.24)2.38 (1.43, 3.97)2.23 (1.69, 2.93)2.05 (1.55, 2.72)No CathCommunity3.86 (2.27, 6.56)2.31 (1.32, 4.06)3.15 (2.33, 4.26)2.06 (1.50, 2.84)

Discussion {#Sec5}
==========

This analysis from a large cohort of geographically diverse patients indicates that regionalization of tertiary ACS services enables access to cardiac catheterization for patients from community centers. Indeed, within this regional care model, patients presenting initially to community hospitals actually had higher rates of cardiac catheterization and revascularization than those presenting initially to the interventional center, and underwent these procedures in a timely fashion.

The advantages of regional care centers for the treatment of ST elevation myocardial infarction (STEMI) have been clearly described \[[@CR12]--[@CR14]\]. Regional approaches to STEMI care focus on rapid identification and early reperfusion therapy with the goal of reducing morbidity and mortality. The essential components of regional STEMI care plans include detailed treatment and transfer protocols, community planning, resources, education, quality improvement analysis and research \[[@CR15]\]. Likewise, the development of regionalized comprehensive stroke centers for the care of patients with acute stroke has addressed disparities in the delivery of stroke services particularly between urban and rural centers \[[@CR16]--[@CR18]\].

Few studies have evaluated the regionalization of care for patients with NSTEMI, particularly in the geographically robust provinces of Canada. The Heart Protection Partnership (HPP) project was an Australian initiative developed to audit compliance with evidence-based treatments in patients with acute coronary syndromes treated at interventional and non-interventional centers across the country. The program identified treatment gaps, particularly in non-interventional centers, and provided feedback to individual centers with the purpose of improving compliance with benchmark standards of care \[[@CR19]\]. Ideally, regional centers for ACS should provide effective and efficient care for patients by improving access to cardiac catheterization, revascularization, specialist physicians and to new technologies or medications not available at other centers. The regional care model within Southern Alberta consists of one PCI capable center that provides specialized procedural cardiac care to numerous smaller and geographically distant community centers. This model's process of care involves a well established referral system for cardiac catheterization whereby direct communication between community and subspecialty physicians, delivery of detailed patient information and efficient risk based triage of community ACS patients translates into timely referral for and access to cardiac catheterization.

Geographic disparity in cardiac catheterization and revascularization rates in ACS are well described. A large registry study in Denmark found higher coronary angiography and revascularization rates in ACS patients residing close to an interventional facility compared to those residing at a further distance, with a higher probability of receiving catheterization and revascularization if admitted directly to an interventional center \[[@CR8]\]. The Dartmouth Atlas of Cardiovascular Health Care in the United States recognized that rates of cardiac catheterization varied substantially from the national average in many referral regions \[[@CR20]\]. Another group of investigators from the United States demonstrated that less than half of patients presenting to community hospitals with ACS were transferred to tertiary hospitals for cardiac catheterization \[[@CR9]\]. This geographical variance has also been described in Canada where investigators in the province of Nova Scotia found lower rates of cardiac catheterization for patients residing outside of a metropolitan area \[[@CR21]\]. Data from the New Zealand Cardiac Society Audit Group demonstrated that patients with ACS admitted to non-interventional centers were less likely to be referred and had longer time delays to access cardiac catheterization compared to those admitted to interventional centers \[[@CR22]\]. In our study we found that despite large geographical barriers of up to 291 Km, patients initially presenting to community hospitals had similar or even greater access to cardiac catheterization compared to those initially presenting to the interventional facility.

Randomized controlled trials and meta-analyses have demonstrated better clinical outcomes in NSTEMI patients treated with an early invasive approach (early cardiac catheterization and revascularization as required for moderate to high risk NSTEMI) \[[@CR22]--[@CR26]\]. These studies showed a consistent reduction in recurrent ischemia and re-infarction but inconsistencies in the survival benefit. In our study we found better 30-day and 1-year outcomes in patients managed invasively compared to those managed conservatively. Due to the observational nature of this study, selection bias may influence outcomes and partially account for baseline differences in patients chosen for cardiac catheterization. This limits generalization of our findings to different populations. Further evaluation of detailed patient characteristics and comorbidities, patient preferences, the shared decision-making process and potential referral physician selection bias are necessary to explain these findings.

In this study, there were no differences in 30-day or 1-year risk adjusted mortality between patients admitted to interventional and community hospitals, despite the differences noted in cardiac catheterization and revascularization rates. Differences in adherence to acute and long- term, guideline based medical therapies, in addition to numerous other patient care factors not evaluated in this study, could account for these findings. Similar findings were noted in a study evaluating outcomes of NSTEMI patients treated in academic and non-academic centers in the United States. Despite higher utilization of guideline based medications, cardiac catheterization and revascularization in academic centers, there were no differences in 1-year mortality compared to non-academic center patients \[[@CR27]\].

Our findings support the development of regional initiatives and processes of care that ensure appropriate access to cardiac catheterization for patients with ACS. Facilitating transfer of patients from hospitals without cardiac catheterization capabilities to regional invasive centers is essential for favorable outcomes in ACS. Such a regional care model successfully exists in Southern Alberta where management practices of non-cardiologists in community centers encompass a strong compliance with evidence-based, regional cardiac catheterization referral guidelines and protocols and an aggressive transfer strategy for invasive investigation is the predominant model of care in community centers. Performance of catheterization within guideline recommended timeframes for all patients is a recognized area for improvement in this regional model. The development of formal repatriation processes of care to ensure availability of catheterization facilities may help to achieve these goals.

This study has limitations. We evaluated cardiac catheterization rates for ACS patients in a Canadian regional model that may differ in structure from other international models; nonetheless, our findings provide insights into important ACS management concepts. Although we demonstrated good clinical outcomes in patients undergoing cardiac catheterization we were unable to determine why some patients were not referred for cardiac catheterization or whether the treatment of conservatively managed patients was optimal. Additionally, our registry does not audit against key performance indicators or provide detailed information regarding guideline based medical therapies. Admission to presenting hospitals was not randomly assigned, and consequently our results may be confounded by other unmeasured factors. However, these limitations are balanced by the strength of our evaluation of a large, unselected group of real-world ACS patients.

Conclusion {#Sec6}
==========

In this large, contemporary, registry-based study we describe a successful regional care model in which ACS patients first admitted to community hospitals have effective access to cardiac catheterization despite geographic and available services barriers. These findings support the importance of regional initiatives and processes of care that facilitate access to cardiac catheterization for ACS patients.
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